|Articles|March 1, 2011
- Applied Clinical Trials-03-01-2011
- Volume 20
- Issue 3
ACT Cover
Cover
Advertisement
Cover
Articles in this issue
over 15 years ago
Applied Clinical Trials Digital Edition - March 2011, Supplementover 15 years ago
Applied Clinical Trials Digital Edition - March 2011over 15 years ago
ACT coverover 15 years ago
Business and News Update March 2011over 15 years ago
Cancer Trials: Raising Accrual Ratesover 15 years ago
Revisions to the Clinical Trials Directiveover 15 years ago
Palm Beach CRO and AOBO Form Partnershipover 15 years ago
Low Hanging Fruit in the Fight Against Inefficiencyover 15 years ago
Researchers Explore Uses of Health System Dataover 15 years ago
Biomarkers and Targeted Therapies UsageAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Protocol Design Doesn't Fail in the Protocol, It Fails in Transition to Trial
5